Clinical Trials Browser

NIH × Has results × Leukemia, Promyelocytic, Acute × Clear all

Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

NCT00313586 2017-02-02

Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Acute

NCT00588809 2015-08-05

Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia

Phase 2 Completed

47 enrolled 9 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Myelodysplastic-Myeloproliferative Diseases

NCT00305773 2014-05-19

Vorinostat in Treating Patients With Acute Myeloid Leukemia

Phase 2 Completed

37 enrolled 11 charts

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

Clinical Trials

Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia

Vorinostat in Treating Patients With Acute Myeloid Leukemia